# Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

> **NCT00727324** · PHASE2 · COMPLETED · sponsor: **AM-Pharma** · enrollment: 22 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** bovine intestinal alkaline phosphatase (BIAP)

## Key facts

- **NCT ID:** NCT00727324
- **Lead sponsor:** AM-Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-11
- **Final completion:** 2006-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-04-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727324, "Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00727324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*